Investing Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study January 2, 2025
Investing Beyond Lithium Completes Unit Private Placement for Gross Proceeds of $250,000 January 1, 2025
Investing Element79 Provides Updates on ASM Formalization and Progress Towards Long-Term Surface Rights Access Agreements January 1, 2025
Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study
Element79 Provides Updates on ASM Formalization and Progress Towards Long-Term Surface Rights Access Agreements
